Perspectives on Enquiry & Evidence
Reflections on the RCT DUPLICATE Study and Increasing Confidence in Real-World Evidence
Randomized clinical trials (RCTs) have long been considered the gold standard for assessing the efficacy of medical treatments, but real-world evidence (RWE) is often more representative of routine clinical care. The RCT DUPLICATE study makes great strides in comparing the two, but the study has its limitations: notably, the lack of quantitative bias analysis.
Use of Rolling-enrollment Designs to Accelerate Clinical Trials
Selecting a Clinical Trial Design: How Broadly Should You Explore?
A Data-Infused Approach to De-Risking Clinical Trials
Use of Bayesian Approach in Basket Trial Design
Starting the Conversation Early: Incorporating Business Considerations in Optimal Selection of Trial Design
New Publication on Adaptive Platform Trials
Trial Selection: From Art to Science
New Dimensions of Clinical Trial Optimization
Subscribe to our weekly newsletter
By submitting you agree to Cytel’s Privacy Notice